DIA, Chicago 2017

Posted:
23
June 2017

Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings worldwide.See below for updated list of upcoming events.

DIA (the Drug Information Association), 2017 18 - 22 June, 2017 | Chicago, USARichmond Pharmacology’s Principal Investigators Dr Taubel and Dr Lorch will be presenting at DIA 2017,ChicagoJoin our CEO Dr Jorg Taubel, who will be presenting on the topic ‘Combined Adaptive Early Phase Trials: From First-Time-in-Human to Proof of Concept in One Protocol’ Tuesday AM – 20th of June.Dr Ulrike Lorch will also be in attendance presenting ‘Combined Adaptive Early Phase Trials: From First-Time-in-Human to Proof of Concept in One Protocol’ her presentation will also take place Tuesday AM –20th June.For more information visit: DIA-2017

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Contributing to our community in 2020

December 17, 2020
Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.
Read more

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

December 14, 2020
Richmond Pharmacology is delighted to welcome the positive Phase Ib results of Cardior Pharmaceuticals lead compound CDR132L for heart failure.
Read more

Marking a milestone for gene editing

November 10, 2020
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001
Read more